查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722933

2025 年至 2033 年靜脈曲張治療市場規模、佔有率、趨勢及預測（按產品、程序、最終用戶和地區）

Varicose Vein Treatment Market Size, Share, Trends and Forecast by Product, Procedure, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球靜脈曲張治療市場規模價值 4.588 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 6.969 億美元，2025 年至 2033 年的複合年成長率為 4.52%。北美目前佔據市場主導地位，到 2024 年其市佔率將超過 47.8%。老齡人口的成長、微創 (MI) 手術的技術進步、人們意識的提高和醫療保健支出的增加，以及主要參與者專注於創新和策略合作以擴大治療選擇和地理覆蓋範圍，這些都是推動市場成長的一些因素。

靜脈曲張治療市場分析：

主要市場促進因素：由於老齡人口中靜脈曲張盛行率的上升以及治療技術的進步，市場正在經歷適度成長。

主要市場趨勢：與傳統手術方法相比，人們開始轉向微創治療方法，因為它們更有效、更能減輕疼痛、恢復期更短。除此之外，影像技術在靜脈曲張治療中的日益融合，提高了治療和結果的精確度，促進了市場的成長。

地理趨勢：北美佔據市場主導地位，這得益於高昂的醫療支出、先進的醫療基礎設施以及大眾對靜脈曲張疾病認知的不斷提高。

競爭格局：靜脈曲張治療行業的主要市場參與者包括 Alma Lasers Ltd.（Sisram Medical Ltd.）、Angiodynamics Inc.、Biolitec AG（BioMed Technology Holdings Ltd.）、Boston Scientific Corporation、Eufoton SRL、Fotona、Medtronic plc、Sciton Inc.、Teleflex Incorporated、Theeleflex P.

挑戰與機會：先進的靜脈曲張治療費用不斷上漲，對於沒有足夠保險覆蓋的患者來說，尤其是在低度開發地區，這可能會影響市場收入。然而，這也為產業參與者創造了機會來開發可負擔的解決方案，讓更廣泛的人群能夠獲得治療。此外，獲得更多健康知識是靜脈曲張治療市場近期的主要發展之一，旨在讓潛在患者了解各種治療方案，並擴大潛在客戶群。

靜脈曲張治療市場趨勢：

治療技術的進步

靜脈內雷射治療 (EVLT)、射頻消融 (RFA) 和超音波導引硬化療法等持續的進步正在將治療方法從侵入性手術轉變為微創 (MI) 和非手術選擇。對於患者來說，這些新技術可以帶來更快的恢復、更少的痛苦、以及更小的術後併發症發生率，這使得手術越來越受歡迎。 2023年全球微創手術市場規模為529億美元。根據IMARC Group的報告，預計到 2032 年市場規模將達到 910 億美元，2024-2032 年期間的複合年成長率為 6%。雷射和射頻設備與影像技術的結合進一步發展，可以對患病靜脈進行更精確的治療，從而推動靜脈曲張治療的需求。公司正在將其收入用於研發（R&D），以充分利用現有技術並提出新的創新。

醫療保健全球化

透過國際合作，醫療保健專業人員可以交流最佳實踐和技術，從而提高全球治療品質。例如，VVT Medical 宣布與 Methapharm 達成策略性分銷協議，在 2023 年 6 月獲得 FDA 批准後，在美國銷售其 ScleroSafe 平台。此次合作利用 Methapharm 在靜脈曲張方面的專業知識，旨在透過 ScleroSafe 的創新、非熱、非腫脹技術改變治療方法。這種全球性的交流保證了不同地區能夠獲得先進的治療技術，並實現護理品質的標準化，從而支持靜脈曲張治療市場的成長。醫療旅遊也是一個因素，患者前往海外尋求更實惠的一流治療。 2023年，全球醫療旅遊產業價值為1,197億美元。 IMARC Group估計，從 2024 年到 2032 年，市場規模將以 20.1% 的複合年成長率擴張，到 2032 年達到 6508 億美元。全球化將提高全球靜脈曲張治療的可及性和質量，從而支持市場擴張和技術進步。

監管部門的批准和支持

獲得監管部門的批准和支持對於推動靜脈曲張治療的發展至關重要。監管機構為新醫療設備和治療方法制定了嚴格的標準並提供明確的核准程序。嚴格的監管環境促使公司投資研究和臨床試驗以推動創新。當局對治療方法的批准建立了醫療保健提供者和患者之間的信任和信心，保證了市場上有安全有效的選擇。此外，強而有力的法規可以加速尖端治療方法進入市場，加快其採用並擴大靜脈曲張治療的現代選擇範圍。 2024 年 4 月，VVT Medical 的 ScleroSafe(TM) 設備獲得韓國食品藥物安全部的批准，在韓國市場取得了重大里程碑。這是在獲得 FDA 510(k) 批准和 CE 標誌後，確認 ScleroSafe(TM) 是治療靜脈曲張的可靠選擇。

靜脈曲張治療市場細分：

按產品分類：

  • 消融設備
  • 射頻消融設備
  • 雷射燒蝕設備
  • 其他
  • 硬化療法注射
  • 其他

消融設備是一個重要的部分，尤其是射頻和雷射消融設備，因為它們是治療靜脈曲張的首選。這些方法可以有效地關閉有問題的靜脈，而且比迄今為止使用的方法侵入性更小，從而減少疼痛並使患者快速康復。射頻消融設備利用熱能加熱並壓塌靜脈，而雷射消融則利用光能達到類似的效果，為喜歡微創治療的患者提供有效的選擇。 2023年全球消融設備市場規模達59億美元。 IMARC Group預測，到 2032 年，該市場的價值將達到 144 億美元，2024 年至 2032 年期間的複合年成長率為 10.2%。

硬化療法注射在業界佔有重要地位，進而影響靜脈曲張治療市場的收入。該技術包括將溶液注射到靜脈曲張，從而形成疤痕並將血液重新引導至更健康的靜脈，最終導致被治療的靜脈消失。該技術之所以被採用，是因為它能夠有效治療輕微靜脈曲張和蜘蛛網狀靜脈，並且易於使用且成本合理。它在門診環境中尤其受歡迎，因為快速康復是一個重要因素。

其他包括一系列附加選擇，例如壓力襪和外科手術。壓力襪通常用作非手術方法來控制症狀並延緩靜脈曲張的進展，特別是在初期或輕微情況下。雖然由於微創（MI）技術的增加，手術現在使用得越來越少，但在其他治療方法無效的嚴重情況下，手術仍然會被使用。該部分服務於廣泛的患者，提供從基本的預防保健到廣泛的外科治療的選擇。

依程序分解：

  • 注射硬化療法
  • 靜脈內消融術
  • 手術結紮和剝離

注射硬化療法佔業界最大佔有率

注射硬化療法是靜脈曲張治療產業中最主要的領域，主要是因為其有效性、低侵入性以及成本效益。該過程包括將硬化劑溶液注入靜脈曲張，以刺激靜脈壁，導致其塌陷和黏合。隨著時間的推移，接受治療的靜脈會逐漸消失並被周圍組織吸收。硬化療法之所以受歡迎，是因為它可以在門診進行，可以快速解決美容問題以及小靜脈曲張和蜘蛛靜脈引起的不適，並且恢復時間短，使其成為既想要有效又想要方便的患者的首選。 2023年，全球硬化療法市場價值為12億美元。 IMARC Group預測，2024 年至 2032 年期間，市場規模將以 5.5% 的年複合成長率(CAGR) 擴張，到 2032 年將達到 20 億美元。

按最終用戶分類：

  • 醫院
  • 診所
  • 流動中心

醫院是主要的細分市場

醫院憑藉其廣泛的治療選擇和處理需要高級醫療干預的複雜病例的能力佔據市場主導地位，從而塑造了積極的靜脈曲張治療市場前景。他們擁有提供各種靜脈曲張治療所需的基礎設施，包括硬化療法和靜脈內消融等侵入性較小的手術，以及手術結紮和剝離等侵入性較大的技術。該科室為尋求專業血管外科醫生和介入放射科醫生提供可靠、有效治療的患者帶來了極大的信心。此外，醫院在治療中發揮關鍵作用，對於需要各種醫療保健提供者的全面護理和長期監測的晚期靜脈曲張患者來說，醫院往往是他們的首選，從而鞏固了其在市場上的地位。

按地區分類：

  • 北美洲
  • 美國
  • 加拿大
  • 亞太
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

北美引領市場，佔據靜脈曲張治療市場最大佔有率

該報告還對所有主要區域市場進行了全面的分析，包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。根據報告，北美是靜脈曲張治療最大的區域市場。

北美佔據最大的市場佔有率，這主要歸功於其大量的醫療保健支出、先進的醫療技術和完善的醫療保健系統。該地區涵蓋美國和加拿大，由於老年居民中靜脈曲張患者數量較多，因此對微創 (MI) 手術的需求很高。根據2023年美國人口普查局的報告，美國65歲及以上人口數量預計將從2022年的5,800萬人增加47%，到2050年增加到8,200萬人。此外，預計該年齡層人口在總人口中的比例將從17%上升到23%。此外，北美擁有頂尖的醫療保健公司和強大的監管框架，鼓勵快速採用新技術，具有優勢。該地區在全球市場的強大影響力也受到其廣泛的保險覆蓋範圍和高度的患者意識的影響。

競爭格局：

市場研究報告也對市場競爭格局進行了全面的分析。也提供了所有主要公司的詳細資料。該行業的一些主要市場參與者包括 Alma Lasers Ltd. (Sisram Medical Ltd.)、Angiodynamics Inc.、Biolitec AG (BioMed Technology Holdings Ltd.)、Boston Scientific Corporation、Eufoton SRL、Fotona、Medtronic plc、Sciton Inc.、Teleflex Incorporated、The Vein Company Ltd、V. Medical.H. Medical.H.

本報告回答的關鍵問題

  • 什麼是靜脈曲張治療
  • 靜脈曲張治療市場有多大
  • 2025-2033年全球靜脈曲張治療市場的預期成長率是多少
  • 推動全球靜脈曲張治療市場的關鍵因素有哪些
  • 根據治療程序，全球靜脈曲張治療市場的主要細分領域是什麼
  • 根據最終用戶來看，全球靜脈曲張治療市場的主要細分市場是什麼
  • 全球靜脈曲張治療市場的主要地區有哪些
  • 全球靜脈曲張治療市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 什麼是靜脈曲張治療？靜脈曲張治療市場有多大？
  • 2025 年至 2033 年期間全球靜脈曲張治療市場的預期成長率為何？
  • 推動全球靜脈曲張治療市場發展的關鍵因素有哪些？
  • 根據程序，全球靜脈曲張治療市場的主要部分是什麼？
  • 根據最終用戶來看，全球靜脈曲張治療市場的領先細分市場是什麼？
  • 全球靜脈曲張治療市場的主要地區有哪些？
  • 全球靜脈曲張治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球靜脈曲張治療市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 消融設備
    • 關鍵部分
      • 射頻消融設備
      • 雷射燒蝕設備
      • 其他
  • 硬化療法注射
  • 其他

第7章：市場區隔：依程序

  • 注射硬化療法
  • 靜脈內消融術
  • 手術結紮和剝離

第8章：市場區隔：按最終用戶

  • 醫院
  • 診所
  • 流動中心

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Alma Lasers Ltd. (Sisram Medical Ltd.)
    • Angiodynamics Inc.
    • Biolitec AG (BioMed Technology Holdings Ltd.)
    • Boston Scientific Corporation
    • Eufoton SRL
    • Fotona
    • Medtronic plc
    • Sciton Inc.
    • Teleflex Incorporated
    • The Vein Company
    • VVT Medical Ltd.
    • WON TECH Co. Ltd
Product Code: SR112025A5494

The global varicose vein treatment market size was valued at USD 458.8 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 696.9 Million by 2033, exhibiting a CAGR of 4.52% from 2025-2033. North America currently dominates the market, holding a market share of over 47.8% in 2024. The growing elderly population, technological advancements in minimally invasive (MI) procedures, increasing awareness and healthcare spending, and key players focusing on innovation and strategic collaborations to expand treatment options and geographic reach are some of the factors impelling the market growth.

Varicose Vein Treatment Market Analysis:

Major Market Drivers: The market is experiencing moderate growth because of the rising prevalence of varicose veins among the aging population and advancements in treatment technologies.

Key Market Trends: There is a shift towards less invasive treatment methods because of their efficacy, reduced pain, and shorter recovery periods compared to traditional surgical methods. Besides this, the growing integration of imaging technologies in varicose vein treatments, which enhances the precision of treatments and outcomes, is contributing to the growth of the market.

Geographical Trends: North America dominates the market, driven by high healthcare expenditure, advanced medical infrastructure, and increasing awareness about varicose vein conditions among the masses.

Competitive Landscape: Some of the major market players in the varicose vein treatment industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd., among many others.

Challenges and Opportunities: The growing cost of advanced varicose vein treatments, which can be prohibitive for patients without adequate insurance coverage, particularly in less developed regions, is influencing the market revenue. Nevertheless, this also creates a chance for industry participants to develop affordable solutions that can increase the availability of treatments to a wider range of people. Moreover, gaining more knowledge about health presents one of the major varicose vein treatment market recent developments to inform potential patients about the various treatment options, broadening the potential customer base.

Varicose Vein Treatment Market Trends:

Technological Advancements in Treatment

Ongoing advancements like endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and ultrasound-guided sclerotherapy are changing treatment approaches from invasive surgeries to minimally invasive (MI) and non-surgical options. For patients, such new technologies promise quicker recovery, less pain, and smaller chances of post-operation complications, which is causing the popularity of the surgeries to grow. In 2023, the size of the global minimally invasive surgery market was US$ 52.9 Billion. As per the report by the IMARC Group, the market is expected to reach US$ 91.0 Billion by 2032, exhibiting a CAGR of 6% during 2024-2032. Further development of lasers and radiofrequency devices in combination with imaging technologies for more pinpoint treatment in the ailing veins is driving the varicose vein treatment demand. Companies are channelizing their revenues for research and development (R&D) to make the best use of technologies existing and to come up with new innovations.

Globalization of Healthcare

By partnering internationally, healthcare professionals exchange best practices and technologies, enhancing the quality of treatment globally. For instance, VVT Medical announced a strategic distribution agreement with Methapharm to market its ScleroSafe platform in the USA, following FDA approval in June 2023. This collaboration leverages Methapharm's expertise in varicose veins, aiming to transform treatment with ScleroSafe's innovative, non-thermal, non-tumescent technique. This worldwide exchange guarantees that advanced treatment techniques are available in different areas with standardization of care quality, supporting the varicose vein treatment market growth. Medical tourism is also a factor, with patients traveling overseas in search of top-notch treatments at more affordable prices. In 2023, the medical tourism industry in the world was valued at US$119.7 billion. The IMARC Group estimates the market would expand at a CAGR of 20.1% from 2024 to 2032, reaching US$ 650.8 billion in 2032. Globalization leads to increased accessibility and improved quality of varicose vein treatments worldwide, supporting market expansion and technological progress.

Regulatory Approvals and Support

Obtaining regulatory approvals and support is essential for advancing the development of varicose vein treatment. Regulatory agencies establish stringent criteria and provide clear approval procedures for new medical devices and treatments. The strict regulatory landscape motivates companies to invest in research and clinical trials to drive innovation. The approval of treatments by authorities builds trust and confidence between healthcare providers and patients, guaranteeing the presence of secure and efficient choices in the market. Furthermore, robust regulations can accelerate the entry of cutting-edge treatments into the market, quickening their adoption and expanding the range of modern options for varicose vein treatment. In April 2024, VVT Medical achieved a major milestone in the Korean market with the approval of its ScleroSafe(TM) device by the Korean Ministry of Food and Drug Safety. This was after the FDA 510(k) clearance and CE Mark, confirming ScleroSafe(TM) as a dependable option for varicose vein treatment.

Varicose Vein Treatment Market Segmentation:

Breakup by Product:

  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Laser Ablation Devices
  • Others
  • Sclerotherapy Injection
  • Others

Ablation devices are an important segment, especially radiofrequency and laser ablation devices, because they are preferred in the treatment of varicose veins. These are effective in shutting off problematic veins with ways that are less invasive than those used hitherto, thereby inflicting less pain and delivering the patient to recovery quickly. Radiofrequency ablation devices utilize thermal energy to heat and collapse the vein, while laser ablation uses light energy to accomplish similar outcomes, providing effective options for patients who prefer less invasive treatments. In 2023, the market size of ablation devices worldwide reached US$ 5.9 billion. IMARC Group forecasts that the market will reach a value of US$ 14.4 billion by 2032, showing a 10.2% CAGR from 2024 to 2032.

Sclerotherapy injections have a solid presence in the industry, thereby influencing the varicose vein treatment market revenue. This technique includes injecting a solution into the varicose veins, which results in scarring and redirecting blood to healthier veins, ultimately causing the treated vein to vanish. The technique is used because of its effectiveness in addressing minor varicose veins and spider veins, its ease of use, and its reasonable cost. It is particularly popular in outpatient settings, where fast recovery is an important factor.

Others encompass a range of additional options, such as compression stockings and surgical procedures. Compression stockings are often utilized as a non-surgical method to control symptoms and delay the advancement of varicose veins, especially in the initial phases or mild instances. Surgical procedures, while less frequently used now because of the increase in minimally invasive (MI) techniques, are still utilized in serious situations when other treatments do not work. This part serves a wide range of patients, providing options from basic preventive care to extensive surgical treatments.

Breakup by Procedure:

  • Injection Sclerotherapy
  • Endovenous Ablation
  • Surgical Ligation and Stripping

Injection sclerotherapy holds the largest share of the industry

Injection sclerotherapy is the most dominant sector in the varicose vein treatment industry, mainly because of its effectiveness, low level of invasiveness, and cost-effectiveness. The process includes injecting a sclerosant solution into the varicose veins to irritate the vein walls, leading them to collapse and bond. As time passes, the vein that has been treated fades away as it gets absorbed back into the surrounding tissue. The popularity of sclerotherapy is enhanced by its ability to be performed in outpatient settings, its quick resolution of cosmetic concerns and discomfort from small varicose and spider veins, and its short recovery time, making it a preferred option for patients wanting both effectiveness and convenience. In 2023, the sclerotherapy market in the world was valued at US$ 1.2 billion. The IMARC Group projects that the market will expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, when it reaches US$ 2.0 billion in 2032.

Breakup by End User:

  • Hospitals
  • Clinics
  • Ambulatory Centers

Hospitals represents the leading market segment

Hospitals dominate the market due to their extensive treatment options and ability to manage complicated cases that require advanced medical interventions, shaping a positive varicose vein treatment market outlook. They have the required infrastructure to offer various types of treatments for varicose veins, including less invasive procedures like sclerotherapy and endovenous ablation and more aggressive techniques such as surgical ligation and stripping. This section benefits a strong level of confidence from patients who are looking for dependable and efficient treatments from specialized vascular surgeons and interventional radiologists. Moreover, hospitals play a key role in are frequently the top choice for patients with advanced varicose veins who may need comprehensive care from various healthcare providers and extended monitoring, solidifying their position in the market.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest varicose vein treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for varicose vein treatment.

North America holds biggest share in the market, mainly due to substantial healthcare expenditure, cutting-edge medical technologies, and a solid healthcare system. This area, encompassing both the United States and Canada, shows a high need for minimally invasive (MI) procedures because of a high number of varicose veins in its elderly residents. As per the 2023 US Census Bureau report, the number of people in the US aged 65 and above was projected to increase by 47% from 58 million in 2022 to 82 million by 2050. Furthermore, it is expected that the percentage of people in this age range in the overall population will rise from 17% to 23%. Furthermore, North America is advantaged by having top healthcare firms and a strong regulatory framework that encourages quick uptake of new technologies. The strong presence of the region in the global market is also influenced by its extensive insurance coverage and high level of patient consciousness.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd.

Key Questions Answered in This Report

  • 1.What is varicose vein treatment?
  • 2.How big is the varicose vein treatment market?
  • 3.What is the expected growth rate of the global varicose vein treatment market during 2025-2033?
  • 4.What are the key factors driving the global varicose vein treatment market?
  • 5.What is the leading segment of the global varicose vein treatment market based on procedure?
  • 6.What is the leading segment of the global varicose vein treatment market based on end user?
  • 7.What are the key regions in the global varicose vein treatment market?
  • 8.Who are the key players/companies in the global varicose vein treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Varicose Vein Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Ablation Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Radiofrequency Ablation Devices
      • 6.1.2.2 Laser Ablation Devices
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Sclerotherapy Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 Injection Sclerotherapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Endovenous Ablation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Surgical Ligation and Stripping
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Angiodynamics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biolitec AG (BioMed Technology Holdings Ltd.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boston Scientific Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eufoton S.R.L.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Fotona
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sciton Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teleflex Incorporated
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 The Vein Company
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 VVT Medical Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 WON TECH Co. Ltd
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Varicose Vein Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Varicose Vein Treatment Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Varicose Vein Treatment Market: Breakup by Procedure (in %), 2024
  • Figure 6: Global: Varicose Vein Treatment Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Varicose Vein Treatment Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Varicose Vein Treatment (Ablation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Varicose Vein Treatment (Ablation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Varicose Vein Treatment (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Varicose Vein Treatment (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Varicose Vein Treatment (Endovenous Ablation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Varicose Vein Treatment (Endovenous Ablation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Varicose Vein Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Varicose Vein Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Varicose Vein Treatment (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Varicose Vein Treatment (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Varicose Vein Treatment (Ambulatory Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Varicose Vein Treatment (Ambulatory Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Varicose Vein Treatment Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Varicose Vein Treatment Industry: SWOT Analysis
  • Figure 76: Global: Varicose Vein Treatment Industry: Value Chain Analysis
  • Figure 77: Global: Varicose Vein Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Varicose Vein Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Varicose Vein Treatment Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Varicose Vein Treatment Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
  • Table 4: Global: Varicose Vein Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Varicose Vein Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Varicose Vein Treatment Market: Competitive Structure
  • Table 7: Global: Varicose Vein Treatment Market: Key Players